Work

Adverse effects of biologics: a network meta‐analysis and Cochrane overview

Year: 2011
Type: article
Abstract: Objectives To compare the adverse effects of therapy with tumour necrosis factor blocker -etanercept (Enbrel), adalimumab (Humira), infliximab (Remicade), golimumab (Simponi) and certolizumab (Cimzia) -interleukin (IL)-1 antagonist -anakinra (Kineret) -IL-6 antagonist -tocilizumab (RoActemra) -anti-CD28 -abatacept (Orencia) -and anti-B cell -rituximab (MabThera)in patients with any disease condition except human immunodeficiency disease (HIV/AIDS).
Source: Prescriber
Language: English
Subfield: Rheumatology
Field: Medicine
Open Access status: bronze
OpenAlex ID: W4253822685
FWCI: 14.7
Cites:
Cited by: 237
Related to: 9